亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C–mutant non-small cell lung cancer

作者
Liu Yifeng,Shigeki Nanjo,Yuya Murase,Sachiko Arai,Satoshi Watanabe,Takeshi Tsuda,Junya Suzuki,Hirokazu Taniguchi,Kazuhiko Shibata,Shigeki Sato,Tsukasa Ueda,Shunichi Nomura,Takahiro Shimizu,Koji Fukuda,Hayato Koba,Takafumi Kobayashi,Yuichi Tambo,Kenta Yamamura,Noriyuki Ohkura,Miki Abo
出处
期刊:Oncogene [Springer Nature]
卷期号:45 (31): 3244-3257
标识
DOI:10.1038/s41388-026-03877-8
摘要

Kirsten rat sarcoma viral oncogene (KRAS) G12C inhibitors have demonstrated clinical efficacy against KRAS G12C-mutant non-small cell lung cancer (NSCLC); however, intrinsic and acquired resistance limit their therapeutic potential. Therefore, combination strategies are needed to address these limitations. While various combination regimens are currently being tested in clinical trials, treatments tailored to specific biomarkers remain underexplored. In this study, intrinsic and acquired KRAS G12C inhibitor-resistant tumor cells were established using patient-derived xenograft (PDX) and mouse models. We identified that tumor cell-autocrine amphiregulin (AREG)-mediated epidermal growth factor receptor (EGFR) phosphorylation plays a pivotal role in both intrinsic and acquired resistance to KRAS inhibitors. Notably, the same resistance mechanism was observed in central nervous system metastatic recurrence in a leptomeningeal carcinomatosis mouse model. RNAscope in situ hybridization detected AREG mRNA in tumor tissues and may serve as a diagnostic tool for assessing AREG expression. Furthermore, combining KRAS inhibitors with EGFR tyrosine kinase inhibitors suppressed tumor growth, effectively overcoming resistance. Notably, high AREG mRNA expression was observed in three of nine tumor samples from patients harboring the KRAS G12C mutation, including two patients who exhibited a poor response to sotorasib and one patient who achieved a partial response. In conclusion, AREG-mediated EGFR activation is a key driver of resistance to KRAS inhibitors in patients with KRAS G12C-mutant NSCLC. Combining EGFR and KRAS inhibition represents a promising strategy to overcome therapeutic resistance and may enhance and prolong clinical benefit in patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai的应助被科研通管家采纳,获得10
4秒前
5秒前
英俊的谷蓝完成签到,获得积分10
9秒前
明理的璎完成签到,获得积分10
27秒前
31秒前
美丽的忆彤完成签到,获得积分10
32秒前
Ava的应助被sun采纳,获得10
48秒前
55秒前
动听一德完成签到,获得积分10
55秒前
领导范儿的应助被ClaraClark591采纳,获得30
58秒前
1分钟前
1分钟前
sun发布了新的文献求助10
1分钟前
ClaraClark591发布了新的文献求助30
1分钟前
威武的又琴完成签到,获得积分10
1分钟前
闪闪小凡完成签到,获得积分10
1分钟前
1分钟前
369ninja发布了新的文献求助10
1分钟前
Tashanzhishi完成签到,获得积分10
1分钟前
优美的烙完成签到,获得积分10
1分钟前
打打的应助被科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
科目三的应助被科研通管家采纳,获得10
2分钟前
奔跑的应助被科研通管家采纳,获得10
2分钟前
愉快的惋庭完成签到,获得积分10
2分钟前
等待剑完成签到,获得积分10
2分钟前
2分钟前
Maestro_S的应助被爱学习的doge采纳,获得10
2分钟前
2分钟前
2分钟前
孙老师完成签到 ,获得积分10
2分钟前
AiQi完成签到 ,获得积分10
3分钟前
sfwrbh完成签到,获得积分10
3分钟前
多情的中蓝完成签到,获得积分10
3分钟前
甜蜜语堂完成签到,获得积分10
3分钟前
李爱国的应助被科研通管家采纳,获得10
4分钟前
Maestro_S的应助被科研通管家采纳,获得10
4分钟前
大医仁心完成签到 ,获得积分0
4分钟前
Ali发布了新的文献求助10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570170
关于积分的说明 21808444
捐赠科研通 7775818
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478958